On Friday, November 9th, the Court of Appeals for the Federal Circuit issued a nonprecedential decision in NuVasive, Inc. v. Iancu, which vacated certain findings of the Patent Trial and Appeal Board (PTAB) in an inter partes reexamination proceeding involving a NuVasive patent covering a system and methods for minimally invasive surgical procedures. The Federal Circuit panel of Circuit Judges Pauline Newman, Raymond Chen and Todd Hughes determined that on the issue of secondary considerations the PTAB erred in finding no nexus between NuVasive’s claimed method and the surgical procedure actually commercialized by NuVasive. The panel also held that further fact-finding was required in order to determine whether an asserted prior art publication teaches a certain nerve-monitoring technique necessary to support the Board’s determination of obviousness. Therefore, the decision of the PTAB was vacated and the case remanded for further proceedings consistent with the Court’s opinion.
The post CAFC finds nexus between minimally invasive surgical patent and commercialized procedure appeared first on IPWatchdog.com | Patents & Patent Law.
CAFC finds nexus between minimally invasive surgical patent and commercialized procedure
No Comments
Patent
- Enablement
- Fee Shifting
- Litigation
- US Inventor Backs SCOTUS Petition to Clarify Claim Construction Principles
- Iancu Says Goodbye, Urges Commitment to ‘American Innovation Renaissance’
- Biden’s Opportunity to Protect American Innovation
- Washington Insiders Say Farewell to 2020 and Look Ahead to 2021
- Innovation Alliance Urges Biden Administration to Support Patent Rights
Recent Posts
- US Inventor Backs SCOTUS Petition to Clarify Claim Construction Principles
- Iancu Says Goodbye, Urges Commitment to ‘American Innovation Renaissance’
- Biden’s Opportunity to Protect American Innovation
- Washington Insiders Say Farewell to 2020 and Look Ahead to 2021
- Innovation Alliance Urges Biden Administration to Support Patent Rights